Search Results - "Kilkku, O."

Effect of selegiline on mortality in patients with Parkinson's disease : A meta-analysis by OLANOW, C. W, MYLLYLÄ, V. V, RINNE, U. K, SOTANIEMI, K. A, LARSEN, J.-P, PALHAGEN, S, PRZUNTEK, H, HEINONEN, E. H, KILKKU, O, LAMMINTAUSTA, R, MÄKI-IKOLA, O

“…The Parkinson's Disease Research Group of the United Kingdom (PDRG-UK) reported increased mortality in PD patients treated with levodopa plus selegiline…”
Get full text

Early selegiline therapy reduces levodopa dose requirement in Parkinson's disease by Myllylä, V V, Heinonen, E H, Vuorinen, J A, Kilkku, O I, Sotaniemi, K A

“…In an earlier report of our placebo-controlled selegiline trial on de novo parkinsonian patients, we have shown that the need to start additional levodopa…”
Get more information

Pharmacokinetics and safety of deramciclane during multiple oral dosing by Kanerva, H, Kilkku, O, Helminen, A, Rouru, J, Scheinin, M, Huupponen, R, Klebovich, I, Drabant, S, Urtti, A

“…Deramciclane is a new putative non-benzodiazepine-type anxiolytic compound. It is a selective serotonin 5-HT(2A) and 5-HT(2C) receptor antagonist and has also…”
Get more information

Effect of adding selegiline to levodopa in early, mild Parkinson's disease. Evidence is insufficient to show that combined treatment increases mortality by Aaltonen, H, Kilkku, O, Heinonen, E, Mäki-Ikola, O

Get full text

Effect of adding selegeline to levodopa in early, mild Parkinson's disease. Other studies have not shown increased mortality by Mäki-Ikola, O, Kilkku, O, Heinonen, E

Get full text

Selegiline Treatment Facilitates Recovery After Stroke by Sivenius, Juhani, Sarasoja, Taneli, Aaltonen, Helena, Heinonen, Esa, Kilkku, Olavi, Reinikainen, Kari

“…Objective: Selegiline (L-deprenyl) is a selective monoamine oxidase B (MAO- B) inhibitor used in the treatment of Parkinson's disease. In addition, it is…”
Get full text

Control of the temporal aspect when considering risk factors for acute otitis media by Alho, O P, Kilkku, O, Oja, H, Koivu, M, Sorri, M

“…A random sample of 2512 children was monitored to age 2 years to study the biologic effects of various risk variables on acute otitis media using a new dynamic…”
Get more information

Which children are being operated on for recurrent acute otitis media? by Alho, O P, Koivu, M, Sorri, M, Oja, H, Kilkku, O

“…To examine at the population level which children were operated on for recurrent acute otitis media episodes, how ill they were, and what factors affected the…”
Get more information

Effect of adding selegiline to levodopa in early, mild Parkinson's disease. Evidence is insufficient to show that combined treatment increases mortality [letter] by Aaltonen, H, Kilkku, O, Heinonen, E, Maki-Ikola, O

Get full text

Brain 5-HT2A receptor occupancy of deramciclane in humans after a single oral administration : a positron emission tomography study by KANERVA, H, VILKMAN, H, NAGREN, K, KILKKU, O, KUOPPAMÄKI, M, SYVÄLAHTI, E, HIETALA, J

“…Deramciclane fumarate is a new 5-HT2A and 5-HT2C receptor antagonist with putative anxiolytic effects. In the present study the binding of deramciclane to…”
Get full text

The effects of early selegiline therapy on long-term levodopa treatment and parkinsonian disability: An interim analysis of a norwegian-danish 5-year study by Larsen, Jan P., Boas, Jette

“…In this study, we investigated the effects of selegiline on levodopa treatment and parkinsonian disability over several years of treatment in patients with…”
Get full text

Longitudinal study of cerebrospinal fluid amyloid proteins and apolipoprotein E in patients with probable Alzheimer's disease by Pirttilä, Tuula, Koivisto, Keijo, Mehta, Pankaj D, Reinikainen, Kari, Kim, Kwang S, Kilkku, Olavi, Heinonen, Esa, Soininen, Hilkka, Riekkinen Sr, Paavo, Wisniewski, Henryk M

“…Levels of soluble amyloid β protein (sA β), amyloid β precursor protein (APP) and apolipoprotein E (apoE) were examined in cerebrospinal fluid (CSF) obtained…”
Get full text

579 Efficacy and safety of selegiline in the long-term treatment of patients with Alzheimer's disease by Riekkinen, P.J., Koivisto, K., Helkala, E.-L., Hänninen, T., Reinikainen, K.J., Kilkku, O., Heinonen, E.

Get full text

The single dose pharmacokinetics and safety of deramciclane in healthy male volunteers by Kanerva, Harri, Kilkku, Olavi, Heinonen, Esa, Helminen, Antti, Rouru, Juha, Tarpila, Simo, Scheinin, Mika, Huupponen, Risto, Klebovich, Imre, Drabant, Sandor, Urtti, Arto

“…The pharmacokinetics and tolerability of a new putative non‐benzodiazepine type anxiolytic compound deramciclane was studied in two consecutive studies. An…”
Get full text

672 Longitudinal study of CSF amyloid proteins and apoE in patients with Alzheimer's disease by Koivisto, K., Pirttilä, T., Mehta, P.D., Reinikainen, K., Kim, K.S., Kilkku, O., Heinonen, E., Riekkinen, P., Wisniewski, H.M.

Get full text

Effect of adding selegiline to levodopa in early, mild Parkinson's disease by Counsell, Carl, Aaltonen, Helena, Kilkku, Olavi, Heinonen, Esa, Mäki-Ikola, Outi

Get full text

Is a child's history of acute otitis media and respiratory infection already determined in the antenatal and perinatal period? by Alho, O P, Koivu, M, Hartikainen-Sorri, A L, Sorri, M, Kilkku, O, Rantakallio, P

“…A random sample of 2512 children were followed up from fetal period to the age of two years and the relation of various antenatal and perinatal factors to…”
Get more information

The effect of sodium cromoglycate eyedrops compared to the effect of terfenadine on acute symptoms of seasonal allergic conjunctivitis by Leino, M, Carlson, C, Kilkku, O, Kumpulainen, T, Kyrönpalo-Kauppinen, S, Laaka, V, Norio, M, Valtola, J

“…A multicentre, group comparative open study was carried out on 68 patients to compare the effects of 2% sodium cromoglycate eyedrops and an oral antihistamine,…”
Get more information